The Medical Letter on Drugs and Therapeutics
FROM
ISSUE1469
ISSUE1469
May 25, 2015
Ceftazidime/Avibactam (Avycaz) - A New Intravenous Antibiotic
Subscribers: Log in to read full article. Not a subscriber? Subscribe or purchase article. |
Ceftazidime/Avibactam (Avycaz) - A New Intravenous Antibiotic
May 25, 2015 (Issue: 1469)
The FDA has approved ceftazidime/avibactam
(Avycaz – Actavis) for IV treatment of complicated
urinary tract and intra-abdominal infections in adults
who have limited or no other treatment options.
Ceftolozane/tazobactam (Zerbaxa – Cubist),...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.